Dr / Khaled Atef Elmounayri President and Managing Director of Misr Medical Products Company, explained in the report of the Board of Directors that the first half of the fiscal year 2019/2020 witnessed an increase in the revenues of the current activity to 213 million pounds against Investigator for the ideal period 175 million, an increase of 22%, and the target for the same period in the 2019/2020 period, by 18% She added that the current activity revenues targeted for the fiscal year 2020/2021 are estimated at 448 million pounds compared to 361 million pounds approved in the estimated budget for 2019/2020 with an increase of 24% and 345 million pounds achieved during 2018/2019, an increase of 30% and the targeted exports are estimated during the year Financial 2020/2021, at an amount of 55 million pounds, and the company's management aims to pump investments of about 45 million pounds during the year 2020/2021 to complete the development and modernization process While the net targeted profit for the year 2020/2021 is estimated at 18 million pounds compared to 6 million pounds approved for 2019/2020 and the amount of 4.2 million pounds achieved for 2018/2019